MarketInOut Stock Screener Log In | Sign Up

Financiere de Tubize

BRU • Healthcare • Biotechnology • Quote as of 10/30/2026
Financiere de Tubize stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeBRU
Market Capitalization9,783.87 mln
Float20.70 mln
Earnings Date08/03/2026

EPS

2.21
Stretched

P / E

104
Highly speculative

Piotroski F-Score

6 / 9
Solid

Relative Strength

98 / 100
Top performer

ROE

5.08
Low

Dividend Yield

0.49%
Negligible

Business Description

Financière de Tubize SA is a Belgian holding company founded in 1928 and headquartered in Brussels, with its entire portfolio consisting of a single ownership stake in UCB, a biopharmaceutical firm. Through this investment, the company has indirect exposure to UCB's work in researching and creating medicines for people living with severe neurological and immune-related conditions.

Key Fundamentals

EPS2.21
P/E104
ROE5.08
ROIC-0.16
ROA5.04
Interest Cover-2.88
EBITDA, mln99.47
EV / EBITDA78.13
EV / EBIT78.13

Quote Details

Last 229.80
Change 2.2 (0.97%)
Open 229.00
Volume 19,371
Turnover 4,451,456
Average Volume 25,347

Financial Ratios

Leverage Ratio1.00
Current Ratio139
Price / Book3.89
Price / Tangible Book3.89
Price / Cash Flow99.47
Price / Free Cash Flow78.46
PEG Ratio1.24

Financial Strength

Piotroski F-Score 6 / 9
Price to Intrinsic Value3.32
Price to Graham Number3.68
Shiller PE Ratio34.95

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.17% 95 / 100   
1 Month 34.23% 98 / 100   
2 Months 8.7% 85 / 100   
6 Months 14.79% 82 / 100   
1 Year 9.75% 57 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog